Codetta Bio Announces Commercial Availability of Concerto™ System and New Customizable Cytokine and Neuroscience Panels at AGBT 2026

2026-02-26 - 05:23

ORLANDO, Fla., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Codetta BioTM, a leader in multi-omic solutions that combine ultrasensitive protein quantification with simultaneous RNA and DNA analysis, today announced major product and commercialization milestones at the AGBT General Meeting. The company has transitioned its ConcertoTM system to commercial production and has begun installing systems at customer sites. Codetta Bio also unveiled its near-term product roadmap, including the upcoming launch of new customizable panels for multi-omic studies of immunology and neuroscience. Read More